MAP2 and Alzheimer disease: As previously mentioned, soluble hyperphosphorylated tau isolated from AD brains has decreased microtubule-promoting activity in vitro [125,199] and sequesters normal tau, MAP1 (A/B) and MAP2, causing the inhibition of microtubule assembly and even the disassembly of microtubules [126,127].